Device Trial Radar · NCT07009132
Cholate Clearance in Fontan and Heart Failure
Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Aug 4, 2025
Primary completion
Dec 2026
Study completion Dec 2031
Sponsor
- Lead sponsor
- HepQuant, LLCNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Pennsylvania
- First posted
- Jun 6, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this study is to use the HepQuant dual cholate clearance assay, which has been shown to measure liver function in people with known chronic liver conditions, to assess severity of Fontan-associated liver disease (FALD). This study aims to understand the role impaired blood flow to the liver plays in liver function in Fontan patients compared to patients with right heart failure and healthy controls. The study will also determine whether cholate clearance is a good measure to use in this population, and whether it will be able to predict clinical outcomes. Participants will undergo a HepQuant dual cholate clearance assay and a cardiac magnetic resonance imaging (MRI) at the beginning of the study, and then data on health status will be collected for 5 years.
Conditions
- Fontan
- Right Heart Failure
Interventions
Dual cholate clearance assayDevice
Study participants are administered labeled oral and intravenous cholate, and then two blood samples are taken over 60-minutes. Serum cholate levels are measured by blood draws.
MRIRadiation
Unsedated non contrast cardiac magnetic resonance imaging (MRI)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hepatic cholate clearanceTime frame: Baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.